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REEVALUATION OF ECT 
(Tilak Venkoba Rao Oration 1985) 
Ravi Abhyankar 
Electroconvulsive therapy has become 
controversial in recent times and its use is 
becoming restricted especially in western 
countries. Post ECT memory deficiency is 
one of the important scientific reasons for 
the non-acceptance of ECT. However poli-
tical, emotional, medicolegal factors and 
mass media have played a more important 
role in the decline of ECT than the scientif-
ic evidence. But in India and other develop-
ing countries ECT is a common therapeutic 
modality. Moreover, it is used not only to 
treat depression, which is regarded as the 
primary indication in the western world, 
but also to treat scizophrenia and mania. 
The diminished use of ECT may have 
been because of poor scientific quality of 
ECT studies. As late as 1980, Salzman ob-
served that there have been no completely 
acceptable prospective studies on the use of 
ECT in schizophrenia, even though ECT 
had been in use for 40 years. Thus a project 
was undertaken at the WHO Collaborat-
ing Centre for Psycho-pharmacology, De-
partment of Psychiatry, K.E.M. Hospital, 
Bombay under the guidance of Prof. V. N. 
Bagadia to study various aspects of ECT in 
schizophrenia and in depression, with em-
phasis on cognitive function evaluation, 
following contemporary standard of clini-
cal research i.e. prospective design, specific 
diagnostic criteria, use of control groups, 
random assignment, blind rater and objec-
tive outcome measures to resolve the dis-
sonance in the attitude towards ECT. 
Manfred Sakel introduced Insulin thera-
py for schizophrenia in 1933, Von Meduna 
used leptazol and campher in oil to produce 
convulsions in 1935, Moniz and Lima de-
veloped frontal leucotomy in 1936 and in 
1938 Cerletti and Bini used electrical cur-
rent to induce convulsions. Like Washing-
ton and his axe these treatments were used 
freely and tried in almost all the psychiatric 
conditions. These treatments appealed to 
people because they were biological inter-
ventions as in other branches of medicine 
and surgery. The memories of dramatic re-
sults produced by Fever therapy developed 
by Wagner-Jouregg were still present and 
it was tempting to try other biological 
treatments. Wagner-Jauregg and Moniz are 
the only two people related to the field of 
Psychiatry who have received the Nobel 
Prize for medicine and physiology. 
Out of all the biological treatments de-
veloped in the 30s, Insulin therapy, Lepta-
zol induced convulsions and frontal leuco-
tomy as practiced by Moniz are more or less 
obsolete and are hardly used today. Only 
Electroconvulsive therapy has survived to 
date but its status is again controversial. The 
decline started in 60s, after psychopharma-
cologic agents were developed, tested and 
found effective and were firmly estab-
lished. 
Delay and Denikar developed chlorpro-
mazine in 1951 and Kuntz developed imi-
pramine in 1953 which still remain two of 
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the most frequently used drugs in psychia-
try. Though all these psychotropic drugs 
are firmly in saddle today and are largely 
responsible for displacing the biological 
treatments; growing awareness of the limi-
tations and risks of long term neuroleptic 
and antidepressant drug treatment has sti-
mulated interest in the Electroconvulsive 
therapy. 
Stimulus Waveform 
The most commonly used waveform to 
induce convulsion is sine wave stimulus 
(Figure 1). It is an oscillating pattern of 
sinusoidal wave with a frequency of 50 
Hertz i.e. it alternates its polarity 50 times 
in a second. As it is the same type of wave-
form used in domestic electricity, not only 
was it first to be used but also remains most 
popular today. Its adjustable parameters are 
voltage or current and the duration of cur-
rent. Generally about 110 volts stimulus 
needs to be applied for about 0.5 second to 
induce a convulsion. 
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Fig. 1 : Wave Forms 
There are some modifications of sine-
wave stimulus. In monophasic alternating 
stimulus, also known as pulsating direct sti-
mulus, which was developed by Delmucs 
and Marsalet, the current is released only 
partially, blocking out half phase in every 
cycle, so that current does not alternate its 
positive and negative poles. It did not have 
any significant advantages over the biphasic 
alternating sinewave stimulus and is hardly 
used today. In ectonus or glissando stimu-
lus, voltage of a typical sinewave stimulus is 
gradually increased to induce the convul-
sion and is brought down gradually. Again 
small amount of current is applied during 
the clonic phase to minimise the violent 
muscular movements. The ectonus or glis-
sando stimulus avoids the sudden jerk and 
loud cry, a characteristic feature of ECT ad-
ministered without anasthesia and which is 
frightening to the lay observer. It also re-
duced compression fractures of spine be-
cause of smooth induction of the tonic 
phase. But it required the current to be 
administered for a longer period, which 
may produce more impairment of memory. 
However, now that ECT is administered 
under general anasthesia with muscle rela-
xants, use of glissando current is not neces-
sary. Friedman and Wilcox had used unidi-
rectional direct current to induce ECT but 
it was not found suitable. 
Liberson (1948) was first to use the low 
energy brief pulse stimulus in early forties 
to produce a seizure with a smaller amount 
of electrical energy and thereby less ad-
verse cognitive side effects. The pulse sti-
mulus can be adjusted for voltage or cur-
rent, duration, pulse width and pulses per 
second. The energy per phase is considerab-
ly lower with the pulse stimulus and a large 
stimulus duration is necessary in order to 
provide the extent of neuronal depolariza-
tion necessary to initiate the seizure. Typi-
cally a pulse stimulus of 800 ma, with a 
pulse width of 0.75 millisecond and 50 RAVI ABHYANKAR 
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pulses per second may need to be applied 
for 1.5 seconds to induce a convulsion. 
Shortening of pulse width helps more effic-
ient seizure induction, but ultrabrief pulses 
(less than 0.5 millisecond duration) may 
cause incomplete and ineffective seizures 
(Cronholm and Ottosson, 1963). 
Various studies have demonstrated that 
there is no significant difference in the effi-
cacy of sine wave and pulse stimulus 
(Weaver et al 1977, Welch et al 1983). 
However, there is a small group of patients 
which is resistant to a combination of pulse 
stimulus and unilateral electrode place-
ment, but which responds well to bilateral 
sinewave stimulus (Lambourn and Gill 
1978, Price 1981). As regards the adverse 
effects of pulse stimulus, Liberson (1984) 
observed that patients woke up earlier and 
there was less confusion and amnesia. Va-
lentine et al (1968) found less amnesia after 
a pulse stimulus in the immediate post ictal 
period, but did not study long term effects. 
Goldstein et al (1977) found no difference 
in the pulse ECT and sinewave ECT 24 
hours after a course. Similar findings were 
noted by Weiner et al (1982) 48 hours after 
last ECT. On EEG, the less intense seizure 
produced by the pulse stimulus is associated 
with less slowing 2 days after a course of 
ECT. 
Spanis and Squire (1981) studied the ef-
fects of pulse and sinewave stimulus in 
mice. They observed that when equated for 
ability to produce a seizure, low energy 
brief pulse stimulus causes as much amnesia 
as a sinewave stimulus. Thus it appears that 
no clear cut differences in the efficacy and 
adverse effects of sinewave and pulse sti-
mulus have been established. 
Electrode Placement 
The most common placement of bilat-
d'Ellas method (Parietal) 
Mullers method (Frontal) 
Reference electrode (Common) 
Fig. 2: 
eral electrodes is in bitemporal position. In 
bilateral bifrontal application, the elec-
trodes are placed more ante*"
:orly in the 
frontal region, but this placement is not 
used by and large because it causes more 
confusion and memory impairment. 
Unilateral ECT was first used by The-
non in 1956 and by Lancaster in 1958 with 
the aim of reducing area of electrical im-
pact. It was also based on the observation 
that focal fits with or without unilateral ap-
plication lead to less confusion. They pre-
ferred nondominant hemisphere assuming 
that brain damage would be less. Another 
reason for using unilateral application was 
an unsubstantiated fear of eye damage with 
the bilateral application. Two methods of 
unilateral electrode placement are com-
monly used (Figure 2). In Muller's method 
reference electrode is placed above the mid 
point of a line between lateral angle of orbit 
and the external auditory meatus. The se-
condary electrode is placed on the middle 
of forehead. In d'Elia's method, reference 
electrode is placed in the same position, 
while secondary electrode is placed about 9 
cms above and behind in parietal area lat-
eral to the vortex. D'Elia's method requires 
only 1/4 electrical energy than Mullar's 38  REEVALUATION OF ECT 
method to induce a convulsion and pro-
duces less confusion and memory difficul-
ties (D'Elia 1970, d'Elia and Wideplam 
1974 and Erman at al 1979). Incomplete 
seizures occur more commonly with uni-
lateral than bilateral stimulation, probably 
because of failure to recruit diencephalic 
centres, which cannot be reliably identified 
when general anasthesia and muscle rela-
xants are used. Presence of such ineffective 
seizures may be responsible for the general 
feeling that unilateral stimulation is less 
effective. It is necessary to monitor seizure 
either by means of an EEG monitor or by 
occluding circulation in the ipsilateral limb 
to observe generalized tonic and clonic 
convulsion. (Halliday et al, 1968). 
In multiple monitered electroconvul-
sive therapy (MM ECT), from 3 to 8 sei-
zures are induced at the interval of few mi-
nutes on a single day. The rationale is to re-
duce the risk of giving general anasthesia 
repeatedly and finish all the seizures under 
a single general anasthesia. Patient is hype-
roxygenated inbetween the seizures with 
the help of artificial ventilation. This tech-
nique differs from regressive ECT. In re-
gresive ECT seizures are induced repeated-
ly to produce confusion and dysorientation, 
while in multiple monitored ECT the aim 
is to avoid confusion and dysorientation. 
The vital signs as well as ECG and EEG are 
continuously monitored to ascertain pa-
tients general condition, cardiac functions 
and to confirm the occurance of a seizure. 
The contusion and memory impairment 
which result from a session of multiple mo-
nitored ECT arc supposed to be compar-
able to that observed after a single ECT. 
However some authors have also reported 
acute organic brain syndrome, and confusi-
onal states after such multiple monitored 
ECT. Kalinowsky (1981) concluded that in 
conventional ECT even without oxygena-
tion, prolonged seizure and neurological 
dysfunction is very rare. The frequency of 
such side effects with multiple monitored 
ECT is striking in view of its limited use 
and that the technique may not be safe. 
Fink (1979a) also observed that there is no 
advantage of multiple monitored ECT over 
conventional ECT. 
Role of ECT in Depression 
Depressed patients were divided into 
two groups. Group A received bilateral 
ECT and placebo. Group B received simu-
lated ECT and imipramine. Highly signific-
ant improvement was observed in both the 
groups. Patients in group A, who received 
ECT and placebo had significantly more 
improvement than patients in group B, 
who received simulated ECT and imipram-
ine, both after 7 and 20 days of treatment. 
(Bagadia et al 1982, 1983d). 
The results obtained in our study con-
firmed earlier observations of Avery and 
Lubrano (1979), Greenblatt (1977), Klic-
pera et al (1979) and also our own observa-
tions (Bagadia and Shah 1962, Bagadia et al 
1979) that ECT produces superior impro-
vement in depression compared with the 
use of antidepressant drugs. Gangadhar etal 
(1982) commented that ECT produced 
quicker improvement in depression. David-
son et al (1978) demonstrated that even in 
refractory depressions, ECT was superior 
to the antidepressant drugs. Avery and Wi-
nokur (1978) commented that relapse rate 
in depression associated with attempted 
suicide decreased more after ECT treat-
ment than after treatment with antidepres-
sant drugs. Price et al (1978) studied dose 
response ratio in ECT. They observed that 
progressive improvement was observed on 
an average upto five ECT and the dose re-
sponse ratio was more favourable for earlier 
treatments. Johnstone (1980) commented RAVI ABHYANKAR  39 
that ECT produces only as much improve-
ment as antidepressent drugs at the end of 
three months, but he has overlooked earlier 
onset of improvement produced by ECT. 
Thus ECT is superior to antidepressant 
drugs in the treatment of depression both in 
terms of speed and degree of recovery. 
Role of ECT in Schizophrenia 
We observed highly significant andsi-
milar improvement in both the groups, 
group A which received ECT and placebo 
and group B which received simulated 
ECT and chlorpromazine and there was no 
statistically significant difference between 
them. (Bagadia et al 1983a, c). 
The improvement as judged by Clinical 
Global Impression was also similar. In the 
group A, one patient suffering from chronic 
undifferentiated schiophrenia dd not im-
prove with ECT and placebo but subse-
quently and after the study period, im-
proved with chlorpromazine. In the group 
B, two patients, both withdrawn catatonic 
schizophrenics did not improve with simu-
lated ECT and chlopromazine but later im-
proved with ECT. 
Thus according to our results, both ECT 
and chlorpromazine produce a similar de-
gree of improvement in schizophrenia. 
While evaluating five treatment modalities 
for schizophrenia, May (1976) observed 
that drugs with or without psychotherapy 
were superior to ECT. But even in his study 
more than 75 per cent of the patients given 
ECT did respond to it. On the other hand 
Langsley et al (1959), King (1960) and 
Childers (1964) observed that there was 
equal improvement in both ECT and drug 
groups. However, our earlier open study 
(Bagadia et al 1970) had shown that greater 
and faster improvement is achieved with 
ECT than with neuroleptics when psy-
chiatric evaluation was done by clinical glo-
bal assessment. The claims regarding dura-
tion of hospital stay are also controversial, 
although Childers (1964) observed that 
drug treated patients have a shorter stay in 
the hospital, Shader (1976) remarked that 
ECT treated patients have a shorter hospi-
talisation. Janakiramaiah et al (1982) 
obseved that concurrent use of ECT with 
chlorpromazine compensates for the lower 
doses of drugs and helps rapid resolution of 
schizophrenia. 
It would appear that both ECT and neu-
roleptic drugs such as chlorpromazine pro-
duce a similar degree of improvement in 
schizophrenia. However, there are few pa-
tients in either group who are resistant to 
one but respond to the other therapeutic 
modality (Greenblatt 1977). 
Bilateral vs Unilateral 
Nondominant ECT 
There was no difference in the impro-
vement observed with bilateral ECT and 
unilateral nondominant ECT in schizoph-
renia in our study (Bagadia et al 1983b). 
However, the improvement was highly sig-
nificant in both the groups. American Psy-
chiatric Association Task Force report on 
ECT (1978) and other workers (e.g. Fraser 
and Glass 1980) have also concluded that 
unilateral nondominant ECT is as efficaci-
ous as bilateral ECT. Abrams and Taylor 
(1976) observed that unilateral ECT pro-
duced less improvement than bilateral 
ECT. One of the reasons of such impression 
about unilateral ECT is presence of incom-
plete seizures which go unnoticed. 
Side Effects of ECT 
The principal side effects and risks of 
convulsive therapy are fractures, memory 
impairment, prolonged or spontaneous sei-
zures and death. With modern treatment 40  REEVALUATION OF ECT 
methods which include anasthesia, oxyge-
nation, forced ventilation and muscle rela-
xants, many of the complications like frac-
ture and prolonged seizure are reduced 
considerably. The incidence of death is 
about 4 per 100,000 treatments with the 
modern technique. The major cause of 
death is the risk associated with anasthesia, 
though the death rate for ECT and its anas-
thesia is less than that for anasthesia alone. 
Thus the main side effect which re-
mains is forgetfulness, largely responsible 
for the negative image of ECT. Every pat-
ient who undergoes an ECT experiences 
amnesia tor the event and he is also con-
fused for a varying period. Usually patients 
do not complain about this type of amnesia. 
When there is an irritating inability to re-
call events which occurred out of treatment 
setting and when the patient forgets things 
that he does complain about it. ECT im-
pairs retention and recall and improves re-
gistration. While registration is impaired 
because of any psychopathology like schi-
zophrenia or depression, ECT causes ante-
rograde amnesia wherein material learned 
after a course of ECT is forgotton. The dif-
ference between immediate learning and 
recall after an interval is known as forget-
ting score. In retrograde amnesia, patient is 
not able to recall events which took place 
before the course of ECT. 
In our depression study group A patients 
which received ECT and placebo, had im-
provement in the post-treatment score on 
all the tests of cognitive battery except 
arithmetic test. The improvement in Koh's 
block design test was significant (p = 0.04) 
(Figure 3). Two patients complained of 
subjective forgetfulness. (Bagadia et al 
1981a, 1983d). In group B which received 
simulated ECT and imipramine, there was 
improvement in the post-treatment scores 
on all the tests of cognitive battery except 
arithmetic test. Both the improvement in 
the Koh's block design test and the deterio-
ration in the arithmetic test were signific-
ant (p = 0.05). There was no significant dif-
ference in the cognitive performance either 
at pretreatment or at post-treatment eva-
luation between the two groups. (Figure 4). 
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In schizophrenia group, improvement 
was observed on the post-treatment evalua-
tion on all the tests of cognitive battery ex-
cept on the sentence repetition tests of in 
group A. The improved performance on 
Koh's Block Design test was significant at 
P = 0.05 in both the groups. (Figures 5 and 
6) The difference in the cognitive functions 
in the two groups either at pre-treatment or 
post-treatment evaluation was not signific-
ant. Subjective forgetfulness was com-
plained by 8 patients who received ECT 
and 3 patients who received simulated ECT 
(Bagadia et al 1983 a, c). 
In the above study no cognitive deficit 
in the tests administered was seen after bi-
lateral bitemporal ECT. Moreover there 
was significant improvement in the scores REEVALUATION OF ECT  41 
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on Koh's Block Design test. Fink (1977), 
Hamilton et al (1979) and Weeks et al 
(1980) have also reported lack of cognitive 
deficit after ECT. Weeks et al have sug-
gested a bidirectional response to explain 
this observation. Impaired cognitive func-
tions in depression and schizophrenia, im-
prove subsequent to the clinical improve-
ment produced by ECT. This effect may 
mask the deterioration produced by the ef-
fect of ECT per se. The improvement is 
more marked on performance tests, which 
reveal greater initial impairment. Subjec-
tive forgetfulness was complained by 15 
percent schizophrenics on chlorpromazine 
and 40 percent schizophrenics and 10 per-
cent depressive who received ECT, in spite 
of lack of memory impairment on the test 
battery. Similar effect was noted by Fink 
(1979) who observed that learning is im-
proved after ECT and retention is impaired. 
Squire (1977) demonstrated that recogni-
tion is least affected and recall after a delay 
is worst affected. The subjective forgetful-
ness was regarded inability to recall mate-
rial learned in the past few days, which ge-
nerally did not interfere in interpersonal, 
social or vocational functions. Further 
work needs to be done to find out objective 
parameters of subjective forgetfulness. 
Subjective forgetfulness was com-
plained by only 10 percent depressives who 
received ECT as against 40 percent schi-
zophrenics. This may be related to psycho-
pathology. Primary thought disorder, the 
hallmark of schizophrenia, is last and least 
to improve after any treatment including 
ECT. The complaint of forgetfulness by 
schizophrenics may be an attempt to ex-
plain the residual thought disturbance. Psy-
chomotor retardation and slowness of 
thinking observed in depression, a primar-
ily affective disorder, is likely to disappear 
completely after treatment. Thus forgetful-
ness is less likely to be a complaint. 
In one of our earlier studies (Bagadia et 
al 1980 a), 60 per cent of depressed patients 
had complained of forgetfulness when six 
direct ECT were administered every alter-
nate day without any artificial ventilation 
and oxygenation. In a later study (Bagadia 
et al 1980 b), where artificial ventilation 
and oxygenation was not used but ECT was 
spaced adequtely, 20 per cent of the de-
pressed patients complained of forgetful-
ness after six direct and unmodified ECT. 42  REEVALUATION OF ECT 
In the present study, (Bagadia et al 1981, 
1983 d) where adequate spacing of ECT as 
well as artificial ventilation and oxygena-
tion were used, 10 per cent of depressed pa-
tients complained of forgetfulness after six 
ECT. It appears that spacing of ECT and 
oxygenation reduces the complaint of for-
getfulness. 
As the cognitive test battery failed to tap 
any impairment after ECT a new cognitive 
test profile was developed in our subsequ-
ent study of: bilateral and nondominant uni-
lateral ECT in schizophrenia to specifically 
study learning, unaided recall and recogni-
tion. It consisted of a set of pictures of 10 
objects of common use in every day life. It 
demonstrated improved cognitive func-
tions in about 40 per cent patients and wor-
sening in about 30 per cent patients from 
both the bilateral and unilateral ECT 
groups. Confabulation i.e. patient recalled a 
picture which was never shown to him was 
observed in about 20 per cent patients from 
both the groups, before and after treatment. 
Subjective forgetfulness was complained 
by 20 per cent patients from both the 
groups, before and after treatment. Subjec-
tive forgetfulness was complained by 20 
per cent patients who received bilateral 
ECT and 5 per cent patients who received 
unilateral ECT (Table 1). Th -re was no sig-
nificant difference in the two groups on ob-
jective testing, but subjective forgetfulness 
was more common in bilateral ECT group 
(Bagadia et al 1983 b). Squire (1977) has 
commented that there is a possibility that 
some of the failures of recall that persist 
after ECT are not detected by the conventi-
onal tests. However he also mentions the 
possibility that patients may have an illu-
sion of memory impairment, it being no 
more than normal forgetfulness. Fraser and 
Glass (1980) observed that in both unilat-
eral and bilateral groups there was impair-
TA6LC 1 
COGNITIVE PROFILE 
GROUP A GROUP B 
LEARNING IMPROVED 8 8 
WORSENED 8 6 
IMPROVED 9 9 
RECALL WORSENED 3 5 
SUBJECTIVE FORGETFULNESS 4 I 
CONFABULATION PRETREATMENT 3 4 
POSTTREATMENT 3 5 
ment on memory function tests before 
treatment and improvement after treat-
ment. 
Thus there is confusing and often con-
tradictory data on the effect of ECT on cog-
nitive functions. One of the reason for this 
may be that patients were tested after last 
ECT. Another reason is that there was no 
uniform instrument to test cognitive func-
tions, various and often non-standardized 
instruments have been used by various 
workers. 
One may conclude that though subjec-
tive forgetfulness is complained after ECT, 
it may not always be reflected in objective 
memory tests. Such forgetfulness is more 
after bilateral ECT, more in schizophrenics 
than in depressives and usually it does not 
interfere with day-to-day interpersonal, so-
cial and vocational functions. Proper spac-
ing of ECT, oxygenation and ventilatory 
support help to reduce forgetfulness. 
Determinants of Prognosis 
The clinical diagnosis, type and severity 
of psychopathology and history are most 
widely used predictors of outcome which 
are the best so far. Patients who are severely RAVI ABHYANKAR  43 
ill, having syndromes of melancholia i.e. en-
dogenous depression, catatonia and mania, 
have the best prognosis with ECT (APA 
1978, Fink 1979 b, Kendell 1981). ECT is 
the preferred treatment in those having re-
current depression and a history of poor re-
sponse to anti-depressant drugs and good 
response to ECT in the earlier episodes. Ac-
cording to Ottosson (1981), a typical de-
pression e.g. with confusional states and de-
lirium respond favourably to ECT and of-
ten require only a few treatments. 
Many authors have proposed prognostic 
indices, based primarily on symptoms and 
observable clinical signs, but their use is not 
found to be superior to the use of clinical 
diagnosis alone. 
In schizophrenia, good results with 
ECT are associated with those clinical fea-
tures which characterise good prognosis in 
general i.e. short duration of illness, acute 
mode of onset, good premorbid personality, 
presence of delusions, hallucinations, cata-
tonic and affective symptoms. ECT is not 
useful in chronic schizophrenia especially 
those with negative symptoms i.e. loss of 
initiative, lack of motivation, anergia etc. 
Simple and hebephrenic subtypes have 
poor prognosis. While acute paranoid schi-
zophrenia has good prognosis, those with 
paranoid personality are resistant to ECT. 
Such patients are mainly responsibile for li-
tigation against psychiatrists and exaggerat-
ed accounts in the mass media. 
Psychometric and personality criteria as predic-
tors of outcome. 
Many clinicians note that normal pre-
morbid personality is a good prognostic fac-
tor. A denial personality (Kahn & Fink 
1959), high acquiescence score on social at-
titude scales (Kahn et al 1960 b), errors on 
figure ground tests (Kahn et al 1960 a) and 
restricted performance on the Rorschach 
test (Kahn & Fink 1960) were associated 
with a good clinical response to ECT. But 
such studies never achieved even a little 
general acceptance. 
When to stop ECT. 
There are no objective criteria about 
the number of ECT to be administered and 
when to stop ECT. ECT is administered in 
decreasing frequency until clinical remis-
sion is achieved. Some workers prefer to ad-
minister few more treatments to consolid-
ate the improvement. Generally depressed 
patients require 4 to 8 and schizophrenic 
and manic patients .6 to 12 ECT. In the ear-
lier days more number of treatments were 
administered. If a patient has proved resis-
tant even after upto 12 ECT, further treat-
ments are not warranted. ECT does not 
prevent relapse, though maintenance ECT 
has been tried, it is not popular. It is advis-
able to maintain the patient on appropriate 
psychotropic drug to prevent relapse. Some 
patients with recurrent affective disorder, 
when faced with the choice of continuing 
lithium for a number of years, with its pos-
sible side effects and those who have re-
sponded well to ECT, may prefer to make a 
course of ECT when they relapse, instead 
of continuing lithium. 
ELECTROPHYSIOLOGICAL 
STUDIES OF ECT 
Good alpha activity and alpha index of 
more than 67% in the pretreatment EEG 
was associated with good response and low 
voltage fast activity with poor response to 
ECT. But this finding is not consistent. In 
Shagass' sedation threshold test, (1957) 
EEG is monitored while short acting 
barbiturate like amyloborbital is adminis-
tered by the intravenous route. The inflec-
tion point at which low voltage fast activity 
appears is known as sedation threshold. 44  REEVALUATION OF ECT 
Low threshold i.e. earlier change brought 
about by a lesser quantity of barbiturate is 
associated with endogenous depression and 
hence better prognosis with ECT. 
Roth (1951) reported better prognosis 
with ECT when the resting EEG delta ac-
tivity was enhanced by intravenous thio-
pental given a few hours after the first to 
third seizures. 
A prominent feature of depressive disor-
der is a shortened time from onset of sleep 
to the first REM period and greater amount 
of REM activity. These changes in the sleep 
characteristics are reversed by ECT. 
BIOCHEMICAL STUDIES 
Funkcnstein test was an early attempt to 
identify a good prognosis predictor to ECT. 
When the rise in blood pressure after intra-
venous epinephrine was greater than 50 
mm of Hg and when the return to baseline 
was delayed by more than 25 minutes after 
intramuscular methocholine, it was sup-
posed to be a good prognosis indicator for 
ECT (Funkcnstein et al 1952). 
There have been extensive biochemical 
studies of ECT and its outcome and many 
changes have been noted. But any of these 
biochemical changes is not related to the 
clinical course and none is useful as a 
predictor of outcome. Urinary MHPG (3 
methoxy 4 hydroxy phenyl glycol) has 
proved to be a useful indicator to determine 
whether a patient is responding or other-
wise to a particular antidepressant drug, but 
the MHPG levels do not have any relation-
ship with ECT (Steiner et al 1979). Studies 
of urinary cyclic AMP (Moyes 1972) and 
calcium ATPase (Choi et al 1977) showed 
an increase with ECT. But its relationship 
to outcome was not clear. Some authors 
have observed decreased urinary, plasma 
and CSF levels of calcium during a course 
of ECT, at a time clinical improvement is 
imminent. Thus it has been postulated that 
the transfer of calcium in brain tissues may 
be a feature of therapeutic process; and mo-
nitoring plasma or urinary calcium may be 
an useful measure to predict the outcome 
of ECT (Flach 1964, Carman & Wyatt 
1977). 
Neuroendocrine Studies 
An overactivity of the hypothalamic pi-
tuitary adrenal (HPA) axis in depression is 
reflected in elevated plasma Cortisol, loss of 
its diurnal rhythmicity and its resistance to 
suppression or early escape from suppres-
sion after oral dexamethasone. The Dexa-
methasone suppression test (DST) is re-
garded as having diagnostic significance 
and its normalisation after clinical recovery 
is also well documented. Thus it can also be 
used to determine the end point of a course 
of ECT i.e. those who continue to have ab-
normal DST may need further ECT. 
Hypoactivity of the hypothalamic - pi-
tuitary - thyroid (HPT) axis is present in 
about 25 % of patients with endogenous de-
pression; but it is not correlated with a 
course of ECT or the outcome of illness. 
The release of growth hormone by hypo-
glycemia, L-dopa or TSH which is ei-
ther reduced, or lacking in depression re-
turns to normal after ECT. 
Mechanism of Action of ECT 
ECT acts on hypothalamus, as demons-
trated by changes in hypothalamic pituitary 
adrenal and hypothalamic pituitary thyroid 
axes. EEG slow waves activity seen after 
ECT is supposed to come from midline 
structures like thalamus and hypothalamus. 
Thus ECT may act by normalizing neu-
roendocrine functions (Fink, 1980). Snyder 
(1980) has postulated that effects of ECT 
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Smith et al (1978) propose that ECT may 
increase the sensitivity of postsynaptic re-
ceptors to brain 5-HT. Modigh (1976) has 
demonstrated enhanced postsynaptic re-
sponses mediated by noradrenalin after 
ECT. Beta adrenergic receptor sensitivity is 
reduced following a course of ECT and fol-
lowing treatment with antidepressant 
drugs (Pandey et al 1979), which correlates 
well with the time course of clinical impro-
vement. There is also a progressive dopam-
ine autoreceptor subsensitivity both after 
ECT and antidepressant drugs (Chiodo 
and Antelman 1980). Some authors have stu-
died increased cerebral blood flow after ECT 
and its localization. 
Kalinowsky has commented that we are 
successfully using a treatment without 
knowing how it works. Though the defini-
tive mechanism is not known yet, some 
pieces in the jigsaw puzzle are being un-
derstood. The theory of mechanism of 
ECT should be able to explain how it works 
in etiologically and phenomenologically di-
verse conditions such as depression, mania 
and schizophrenia. 
Medicolegal Aspects of ECT 
In our country, medicolegal problems 
about ECT are conspicuous by their ab-
sence and are exception rather than rule. 
Indian patients have greater faith in their 
physicians than their western counterparts, 
and Indian doctors take more interest in 
their patients and go out of their way to 
help them than their western counterparts. 
It makes a lot of difference whether facts 
about ECT are mentioned in a mechanised, 
impersonal statistics or whether the patient 
and relative are actively encouraged to take 
a decision giving them a realistic expecta-
tion without frightening them. Patients and 
relatives often leave the decision making 
about ECT to the psychiatrist himself. A 
healthy, active doctor patient relationship 
helps to prevent medico-legal complica-
tions. 
At present, except for patients detained 
under the Indian Lunacy Act, ECT is admi-
nistered with the fully informed consent of 
the patients and relatives. When the new 
Mental Health Bill becomes a law, it will be 
possible legally to administer treatment to a 
violent, unco-operative and disturbed pat-
ient with the concurrance of another phy-
sician or relatives, even if patient himself is 
not in a position to give consent. Salzman 
(1977) comments that it is not often rea-
lized that it is as much illegal not to admi-
nister ECT and deny it to a patient who 
needs or demands it for genuine indi-
cation as much as administering ECT 
against patient's wish. 
Wither ECT 
Ultimately it is the personal decision of 
the treating psychiatrist in administering 
any treatment to a patient under his care. 
His decision may be influenced by the 
scientific evidence about the advantages 
and disadvantages as well as his likes, dis-
likes, personal experience and also current 
status of the treatment. 
While selecting or discarding ECT, one 
must weigh expected improvement, likely 
side effects, probable consequence of not 
receiving ECT and potential side effects of 
other alternative treatments. The psycho-
tropic drugs also have certain risks, though 
not often clearly defined. Tricyclic antide-
pressants have a latency of 1 -2 weeks, have 
anticholinergic side effects which may be 
troublesome in the elderly and may preci-
pitate cardiac complications. The use of 
monoamine oxidase inhibitors is also 
restricted by hypertensive crises, toxicity 
and interaction with another substances. 46  REEVALUATION OF ECT 
Lithium has the risk of blood dyscrasia, en-
docrine, renal and neurological side effects 
on long term treatment. Neuroleptic drugs 
may lead to tardive dyskinesia, hepatic dys-
function, lenticular opacities and blood dys-
crasias. 
ECT is superior to antidepressant drugs 
in the treatment of depression, is as effec-
tive as neuroleptics in the treatment of schi-
zophrenia and mania. Most of the patients 
are free from any significant side effects. 
Forgetfulness, when present in some pa-
tients, is usually mild and transient and or-
dinarily does not interfere with day to day 
functioning. That ECT is cheap and re-
duces or avoids hospitalization weigh in fa-
vour of ECT in our country. Electroconvul-
sive therapy is a potent tool in psychiatry, 
with its desirable and undesirable effects. It 
should be used for rightful indications, fol-
lowing the proper procedure and precau-
tions to avoid misuse and improper use. 
In the popular press and lay people ECT 
has a negative impression which is not 
helped either by the colloquial term 
'Electric Shock Treatment' or by the con-
notation of frightening jerks associated 
with ECT. But in clinical practice, patients 
and relatives readily agree to ECT when 
explained and as a matter of fact, many pa-
tients demand ECT. The pursuit of know-
ledge regarding ECT needs to be continued 
for better understanding of its effects, me-
chanism and site of action. 
Let me conclude this oration by reciting 
a prayer from Rigveda -
cnrraTTT ^li^M 
Lead me to truth, not to untruth. Lead 
me to light, not to darkness, and to eternity 
not to oblivion. 
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